|
UNITED STATES
|
|
|
SECURITIES AND EXCHANGE
COMMISSION
|
|
|
Washington, D.C. 20549
|
|
|
SCHEDULE 13D
|
|
Under the Securities
Exchange Act of 1934
(Amendment No. 1)
Radiation
Therapy Services, Inc.
(Name of Issuer)
Common
Stock, par value $0.0001 per share
(Title of Class of
Securities)
(CUSIP Number)
James
L. Elrod, Jr.
Vestar
Capital Partners V, L.P.
245
Park Avenue, 41st Floor
New
York, New York 10167
(212)
351-1600
(Name, Address and
Telephone Number of Person
Authorized to Receive Notices and Communications)
With a copy to:
Michael Movsovich
Kirkland & Ellis LLP
153 East 53rd Street
New York, New York 10022
(Date of Event which
Requires Filing of this Statement)
If the filing person has previously filed a
statement on Schedule 13G to report the acquisition that is the subject of
this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or
Rule 13d-1(g), check the following box.
o
Note:
Schedules filed in paper format shall include
a signed original and five copies of this schedule, including all
exhibits. See Rule 13d-7 for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be
filled out for a reporting persons initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing
information which would alter disclosures provided in a prior cover page.
The information required on
the remainder of this cover page shall not be deemed to be filed for the
purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or
otherwise subject to the liabilities of that section of the Act but shall be
subject to all other provisions of the Act (however, see the Notes)
CUSIP No.
750323206
|
|
|
1.
|
Names of Reporting Persons. I.R.S. Identification
Nos. of above persons (entities only)
Radiation Therapy Investments, LLC
|
|
|
2.
|
Check the Appropriate Box
if a Member of a Group (See Instructions)
|
|
|
(a)
|
o
|
|
|
(b)
|
x
|
|
|
3.
|
SEC Use Only
|
|
|
4.
|
Source of Funds (See
Instructions)
BK, AF
|
|
|
5.
|
Check if Disclosure of Legal Proceedings Is
Required Pursuant to Items 2(d) or 2(e)
o
|
|
|
6.
|
Citizenship or Place of Organization
Delaware
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
7.
|
Sole Voting Power
0
|
|
8.
|
Shared Voting Power
9,811,140 (1) (See Item 5)
|
|
9.
|
Sole Dispositive Power
0
|
|
10.
|
Shared Dispositive Power
0
|
|
|
11.
|
Aggregate Amount
Beneficially Owned by Each Reporting Person
9,811,140 (1) (See Item 5)
|
|
|
12.
|
Check if the Aggregate
Amount in Row (11) Excludes Certain Shares (See Instructions)
o
|
|
|
13.
|
Percent of Class
Represented by Amount in Row (11)
40.4%
|
|
|
14.
|
Type of Reporting Person
(See Instructions)
OO
|
|
|
|
|
|
|
(1) Includes 603,077 shares issuable upon exercise of options
exercisable within 60 days of October 19, 2007.
2
CUSIP No.
750323206
|
|
|
1.
|
Names of Reporting Persons. I.R.S. Identification
Nos. of above persons (entities only)
Vestar Capital Partners V, L.P.
|
|
|
2.
|
Check the Appropriate Box
if a Member of a Group (See Instructions)
|
|
|
(a)
|
o
|
|
|
(b)
|
x
|
|
|
3.
|
SEC Use Only
|
|
|
4.
|
Source of Funds (See
Instructions)
BK, AF
|
|
|
5.
|
Check if Disclosure of Legal Proceedings Is
Required Pursuant to Items 2(d) or 2(e)
o
|
|
|
6.
|
Citizenship or Place of Organization
Cayman Islands
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
7.
|
Sole Voting Power
0
|
|
8.
|
Shared Voting Power
9,811,140 (1) (See Item 5)
|
|
9.
|
Sole Dispositive Power
0
|
|
10.
|
Shared Dispositive Power
0
|
|
|
11.
|
Aggregate Amount
Beneficially Owned by Each Reporting Person
9,811,140 (1) (See Item 5)
|
|
|
12.
|
Check if the Aggregate
Amount in Row (11) Excludes Certain Shares (See Instructions)
o
|
|
|
13.
|
Percent of Class
Represented by Amount in Row (11)
40.4%
|
|
|
14.
|
Type of Reporting Person
(See Instructions)
PN
|
|
|
|
|
|
|
(1) Includes 603,077 shares issuable upon exercise of
options exercisable within 60 days of October 19, 2007.
3
CUSIP No.
750323206
|
|
|
1.
|
Names of Reporting Persons. I.R.S. Identification
Nos. of above persons (entities only)
Vestar Associates V, L.P.
|
|
|
2.
|
Check the Appropriate Box
if a Member of a Group (See Instructions)
|
|
|
(a)
|
o
|
|
|
(b)
|
x
|
|
|
3.
|
SEC Use Only
|
|
|
4.
|
Source of Funds (See
Instructions)
BK, AF
|
|
|
5.
|
Check if Disclosure of Legal Proceedings Is
Required Pursuant to Items 2(d) or 2(e)
o
|
|
|
6.
|
Citizenship or Place of Organization
Scotland
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
7.
|
Sole Voting Power
0
|
|
8.
|
Shared Voting Power
9,811,140 (1) (See Item 5)
|
|
9.
|
Sole Dispositive Power
0
|
|
10.
|
Shared Dispositive Power
0
|
|
|
11.
|
Aggregate Amount
Beneficially Owned by Each Reporting Person
9,811,140 (1) (See Item 5)
|
|
|
12.
|
Check if the Aggregate
Amount in Row (11) Excludes Certain Shares (See Instructions)
o
|
|
|
13.
|
Percent of Class
Represented by Amount in Row (11)
40.4%
|
|
|
14.
|
Type of Reporting Person
(See Instructions)
PN
|
|
|
|
|
|
|
(1) Includes 603,077 shares issuable upon exercise of
options exercisable within 60 days of October 19, 2007.
4
CUSIP No.
750323206
|
|
|
1.
|
Names of Reporting Persons. I.R.S. Identification
Nos. of above persons (entities only)
Vestar Managers V Ltd.
|
|
|
2.
|
Check the Appropriate Box
if a Member of a Group (See Instructions)
|
|
|
(a)
|
o
|
|
|
(b)
|
x
|
|
|
3.
|
SEC Use Only
|
|
|
4.
|
Source of Funds (See
Instructions)
BK, AF
|
|
|
5.
|
Check if Disclosure of Legal Proceedings Is
Required Pursuant to Items 2(d) or 2(e)
o
|
|
|
6.
|
Citizenship or Place of Organization
Cayman Islands
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
7.
|
Sole Voting Power
0
|
|
8.
|
Shared Voting Power
9,811,140 (1) (See Item 5)
|
|
9.
|
Sole Dispositive Power
0
|
|
10.
|
Shared Dispositive Power
0
|
|
|
11.
|
Aggregate Amount
Beneficially Owned by Each Reporting Person
9,811,140 (1) (See Item 5)
|
|
|
12.
|
Check if the Aggregate
Amount in Row (11) Excludes Certain Shares (See Instructions)
o
|
|
|
13.
|
Percent of Class
Represented by Amount in Row (11)
40.4%
|
|
|
14.
|
Type of Reporting Person
(See Instructions)
CO
|
|
|
|
|
|
|
(1) Includes 603,077 shares issuable upon exercise of
options exercisable within 60 days of October 19, 2007.
5
CUSIP No.
750323206
|
|
|
1.
|
Names of Reporting Persons. I.R.S. Identification
Nos. of above persons (entities only)
Daniel E. Dosoretz
|
|
|
2.
|
Check the Appropriate Box
if a Member of a Group (See Instructions)
|
|
|
(a)
|
o
|
|
|
(b)
|
x
|
|
|
3.
|
SEC Use Only
|
|
|
4.
|
Source of Funds (See
Instructions)
Not applicable
|
|
|
5.
|
Check if Disclosure of Legal Proceedings Is
Required Pursuant to Items 2(d) or 2(e)
o
|
|
|
6.
|
Citizenship or Place of Organization
United States
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
7.
|
Sole Voting Power
0
|
|
8.
|
Shared Voting Power
3,897,027 (2) (See Item 5)
|
|
9.
|
Sole Dispositive Power
3,897,027 (2) (See Item 5)
|
|
10.
|
Shared Dispositive Power
0
|
|
|
11.
|
Aggregate Amount Beneficially
Owned by Each Reporting Person
3,897,027 (2)
|
|
|
12.
|
Check if the Aggregate
Amount in Row (11) Excludes Certain Shares (See Instructions)
o
|
|
|
13.
|
Percent of Class
Represented by Amount in Row (11)
16.0%
|
|
|
14.
|
Type of Reporting Person
(See Instructions)
IN
|
|
|
|
|
|
|
(2) Includes 403,077 shares issuable upon exercise of
options exercisable within 60 days of October 19, 2007.
6
CUSIP No.
750323206
|
|
|
1.
|
Names of Reporting Persons. I.R.S. Identification
Nos. of above persons (entities only)
Howard M. Sheridan
|
|
|
2.
|
Check the Appropriate Box
if a Member of a Group (See Instructions)
|
|
|
(a)
|
o
|
|
|
(b)
|
x
|
|
|
3.
|
SEC Use Only
|
|
|
4.
|
Source of Funds (See
Instructions)
Not applicable
|
|
|
5.
|
Check if Disclosure of Legal Proceedings Is
Required Pursuant to Items 2(d) or 2(e)
o
|
|
|
6.
|
Citizenship or Place of Organization
United States
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
7.
|
Sole Voting Power
0
|
|
8.
|
Shared Voting Power
2,261,159 (See Item 5)
|
|
9.
|
Sole Dispositive Power
2,261,159 (See Item 5)
|
|
10.
|
Shared Dispositive Power
0
|
|
|
11.
|
Aggregate Amount
Beneficially Owned by Each Reporting Person
2,261,159 (See Item 5)
|
|
|
12.
|
Check if the Aggregate
Amount in Row (11) Excludes Certain Shares (See Instructions)
o
|
|
|
13.
|
Percent of Class
Represented by Amount in Row (11)
9.3%
|
|
|
14.
|
Type of Reporting Person
(See Instructions)
IN
|
|
|
|
|
|
|
7
CUSIP No.
750323206
|
|
|
1.
|
Names of Reporting Persons. I.R.S. Identification
Nos. of above persons (entities only)
James H. Rubenstein
|
|
|
2.
|
Check the Appropriate Box
if a Member of a Group (See Instructions)
|
|
|
(a)
|
o
|
|
|
(b)
|
x
|
|
|
3.
|
SEC Use Only
|
|
|
4.
|
Source of Funds (See
Instructions)
Not applicable
|
|
|
5.
|
Check if Disclosure of Legal Proceedings Is
Required Pursuant to Items 2(d) or 2(e)
o
|
|
|
6.
|
Citizenship or Place of Organization
United States
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
7.
|
Sole Voting Power
0
|
|
8.
|
Shared Voting Power
2,624,745 (3) (See Item 5)
|
|
9.
|
Sole Dispositive Power
2,624,745 (3) (See Item 5)
|
|
10.
|
Shared Dispositive Power
0
|
|
|
11.
|
Aggregate Amount
Beneficially Owned by Each Reporting Person
2,624,745 (3) (See Item 5)
|
|
|
12.
|
Check if the Aggregate
Amount in Row (11) Excludes Certain Shares (See Instructions)
o
|
|
|
13.
|
Percent of Class
Represented by Amount in Row (11)
10.8%
|
|
|
14.
|
Type of Reporting Person
(See Instructions)
IN
|
|
|
|
|
|
|
(3) Includes 200,000 shares issuable upon exercise of
options exercisable within 60 days of October 19, 2007.
8
CUSIP No.
750323206
|
|
|
1.
|
Names of Reporting Persons. I.R.S. Identification
Nos. of above persons (entities only)
Michael J. Katin
|
|
|
2.
|
Check the Appropriate Box
if a Member of a Group (See Instructions)
|
|
|
(a)
|
o
|
|
|
(b)
|
x
|
|
|
3.
|
SEC Use Only
|
|
|
4.
|
Source of Funds (See
Instructions)
Not Applicable
|
|
|
5.
|
Check if Disclosure of Legal Proceedings Is
Required Pursuant to Items 2(d) or 2(e)
o
|
|
|
6.
|
Citizenship or Place of Organization
United States
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
7.
|
Sole Voting Power
0
|
|
8.
|
Shared Voting Power
1,028,209 (See Item 5)
|
|
9.
|
Sole Dispositive Power
1,028,209 (See Item 5)
|
|
10.
|
Shared Dispositive Power
0
|
|
|
11.
|
Aggregate Amount
Beneficially Owned by Each Reporting Person
1,028,209 (See Item 5)
|
|
|
12.
|
Check if the Aggregate
Amount in Row (11) Excludes Certain Shares (See Instructions)
o
|
|
|
13.
|
Percent of Class
Represented by Amount in Row (11)
4.2%
|
|
|
14.
|
Type of Reporting Person
(See Instructions)
IN
|
|
|
|
|
|
|
9
THIS AMENDMENT NO. 1 RELATES TO THE SCHEDULE 13D
ORIGINALLY FILED ON BEHALF OF THE REPORTING PERSONS WITH THE SECURITIES AND
EXCHANGE COMMISSION ON OCTOBER 29, 2007.
THE SAID SCHEDULE 13D IS HEREBY AMENDED TO ADD CERTAIN DISCLOSURE
REGARDING A MANAGEMENT AGREEMENT UNDER ITEM 6 CONTRACTS, ARRANGEMENTS,
UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER AND
ITEM 7 MATERIALS TO BE FILED AS EXHIBITS.
Item 6. Contracts, Arrangements, Understandings or
Relationships with Respect to Securities of the Issuer.
The information contained in Item 6 of the Statement
is hereby amended and restated as follows:
SUPPORT AND VOTING AGREEMENTS
The information set forth under Item 4 is hereby
incorporated by reference.
ROLLOVER SUBSCRIPTION AGREEMENTS, LLC AGREEMENT AND
SECURITYHOLDERS AGREEMENT
Pursuant to the Support Agreements, each Management
Holder has agreed to enter into a Management Stock Contribution and Unit
Subscription Agreement substantially in the form attached hereto within Exhibit 99.8,
99.9, 99.10 or 99.11, respectively (collectively, the Rollover Subscription
Agreements), pursuant to which each such holder will contribution a portion of
his shares of Common Stock to RTI immediately prior to the effective time of
the Merger in exchange for units of limited liability company interest in RTI. Each Rollover Subscription Agreement
contains, among other provisions, certain call options as more fully described
within Exhibits 99.8 through 99.11. In
addition, the Rollover Subscription Agreement with Dr. Daniel E. Dosoretz
gives Dr. Dosoretz a put option, exercisable after the third anniversary
of the closing date of the Merger, with respect to an amount of equity in RTI
not to exceed the value of the shares of Common Stock contributed by him in
connection with the Merger in the event his employment with the Issuer (as the
surviving corporation in the Merger) is terminated by the Issuer without
cause (as defined in the Rollover Subscription Agreement) or by Dr. Dosoretz
for good reason (as defined in the Rollover Subscription Agreement) and, at
the time of such termination, the Issuer meets certain performance targets, as
more fully described within Exhibit 99.8.
In connection with the Management Holders
subscription for equity interest in RTI, each such holder will also execute an
amended and restated limited liability company agreement of RTI substantially
in the form attached hereto as Exhibit 99.5 (the LLC Agreement), and a
securityholders agreement substantially in the form attached hereto as Exhibit 99.6
(the Securityholders Agreement). The
LLC Agreement will set forth certain terms of limited liability interests in
RTI, including, without limitation, the right of members to receive
distributions from distributable assets of RTI, as more fully described in Exhibit 99.5. The Securityholders Agreement will set forth,
among other things, the composition of the board of managers of RTI,
restrictions on the transfer of securities owned by Vestar or the Management
Holders (in each case subject to certain exemptions), registration rights,
tag-along rights, drag-along rights and preemptive rights, in each case as
more fully described in Exhibit 99.6.
MANAGEMENT AGREEMENT
The Issuer, Holdings and RTI have agreed to enter
into a management agreement (the Management Agreement) with Vestar Capital
Partners relating to certain advisory and consulting services Vestar Capital
Partners will render to the Issuer, Holdings and RTI after the consummation of
the Merger. Under the Management Agreement, Vestar Capital Partners will
receive a $10 million transaction fee upon the closing of the Merger for
services rendered in connection with the consummation of Merger and be
reimbursed for its reasonable out of pocket expenses. The Management Agreement
also provides for
10
Vestar Capital Partners to receive an annual
management fee equal to the greater of (i) $850,000 or (ii) an amount
equal to 1.0% of the Issuers consolidated EBITDA, which fee will be payable
quarterly. Holdings, RTI and the Issuer will indemnify Vestar Capital Partners
and its affiliates against all losses, claims, damages and liabilities arising
out of the performance by Vestar Capital Partners of its services pursuant to
the Management Agreement, other than those that have resulted primarily from
the gross negligence or willful misconduct of Vestar Capital Partners and/or
its affiliates. A complete copy of the
Management Agreement is filed as Exhibit 99.12 hereto.
EMPLOYMENT AGREEMENTS
Pursuant to the Support Agreements, the Management
Holders have also agreed to enter into certain employment agreements with
Holdings, the Issuer (as the surviving corporation in the Merger), and/or 21st
Century Oncology, Inc., a wholly-owned subsidiary of the Issuer (21st
Century), which employment agreements are attached hereto within Exhibit 99.8
through 99.11 (collectively, the Employment Agreements). The Employment Agreement (or Employment
Agreements) for each Management Holder sets forth the terms and conditions of
such persons employment as an officer of the Issuer and/or a physician of 21st
Century after the consummation of the Merger, including, without limitation,
compensation, severance benefits and covenant-not-to-compete, in each case as
more fully described within Exhibits 99.8 through 99.11. In addition, the Employment Agreement with Dr. Dosoretz
provides that in consideration of Dr. Dosoretz agreement not to engage in
certain competitive activities until the later of (x) the fifth
anniversary of the closing date of the Merger and (y) three years after
the termination of his employment with the Issuer, the Issuer shall pay Dr. Dosoretz
$6,000,000 in cash, payable in three equal installments on the closing date of
the Merger and the first and second anniversary of the closing date, provided
that the Issuer will have no further obligation to make any such payment if Dr. Dosoretz
materially breaches his covenant-not-to-compete.
EQUITY INCENTIVE PLAN AND INCENTIVE UNIT
SUBSCRIPTION AGREEMENTS
Pursuant to the Support Agreements, the Management
Holders have also agreed to accept certain incentive equity arrangements. The Management Holders will be eligible to
participate in a unit award plan substantially in the form attached hereto as Exhibit 99.7
(the Equity Incentive Plan), pursuant to which the board of managers of RTI
will be authorized to issue units of limited liability company interests to the
Management Holders. The units granted
under the Equity Incentive Plan will be subject to both time-based and performance-based
vesting. The Management Holders will
subscribe for the units granted under the Equity Incentive Plan pursuant to a
Management Unit Subscription Agreement substantially in the form attached
within Exhibits 99.8 through 99.11 (collectively, the Incentive Unit
Subscription Agreements).
The descriptions of the Support Agreements and the
forms of the Rollover Subscription Agreement, the LLC Agreement, the
Securityholders Agreement, the Management Agreement, the Employment Agreements,
the Incentive Unit Plan and the Incentive Unit Subscription Agreements do not
purport to be complete and are qualified in their entirety by reference to the
complete text of such agreements, copies of which are filed as Exhibits hereto
and incorporated herein by reference.
Except for the agreements described above or in
response to Items 3 and 4 of this Schedule 13D, which are hereby incorporated
herein by reference, to the best knowledge of the Reporting Persons, there are
no contracts, arrangements, understandings or relationships (legal or otherwise)
between the persons enumerated in Item 2 of this Schedule 13D, and any other
person, with respect to any securities of the Issuer, including, but not
limited to, transfer or voting of any of the securities, finders fees, joint
ventures, loan or option agreements, puts or calls, guarantees of profits,
divisions of profits or loss, or the giving or withholding of proxies.
11
Item 7. Material to Be Filed as
Exhibits.
Exhibit 99.1
|
Amended
and Restated Joint Filing Agreement, dated December 26, 2007, by and
among the Reporting Persons.*
|
|
|
Exhibit 99.2
|
Agreement
and Plan of Merger, dated as of October 19, 2007, by and among Radiation
Therapy Services, Inc., Radiation Therapy Services Holdings, Inc.,
RTS MergerCo, Inc. and for purposes of Section 7.2 only, Radiation
Therapy Investments, LLC.*
|
|
|
Exhibit 99.3
|
Commitment
Letter, dated as of October 19, 2007, by and among Wachovia Bank,
National Association, Wachovia Investment Holdings, LLC, Wachovia Capital Markets,
LLC and Radiation Therapy Services Holdings, Inc.*
|
|
|
Exhibit 99.4
|
Equity
Commitment Letter, dated as of October 19, 2007, by and between Vestar
Capital Partners V, L.P. and Radiation Therapy Services Holdings, Inc.*
|
|
|
Exhibit 99.5
|
Form of
Amended and Restated Limited Liability Company Agreement of Radiation Therapy
Investments, LLC.*
|
|
|
Exhibit 99.6
|
Form of
Securityholders Agreement by and among Radiation Therapy Investments, LLC and
the securityholders party thereto.*
|
|
|
Exhibit 99.7
|
Form of
Radiation Therapy Investments, LLC 2008 Unit Award Plan.*
|
|
|
Exhibit 99.8
|
Support
and Voting Agreement, dated as of October 19, 2007, by and among
Radiation Therapy Investments, LLC, Radiation Therapy Services Holdings, Inc.
and Daniel E. Dosoretz, including forms of Rollover Subscription Agreement,
Employment Agreements and Incentive Unit Subscription Agreement attached as
exhibits thereto.*
|
|
|
Exhibit 99.9
|
Support
and Voting Agreement, dated as of October 19, 2007, by and among
Radiation Therapy Investments, LLC, Radiation Therapy Services Holdings, Inc.
and Howard M. Sheridan, including forms of Rollover Subscription Agreement,
Employment Agreement and Incentive Unit Subscription Agreement attached as
exhibits thereto.*
|
|
|
Exhibit 99.10
|
Support
and Voting Agreement, dated as of October 19, 2007, by and among
Radiation Therapy Investments, LLC, Radiation Therapy Services Holdings, Inc.
and James H. Rubenstein, including forms of Rollover Subscription Agreement,
Employment Agreements and Incentive Unit Subscription Agreement attached as
exhibits thereto.*
|
|
|
Exhibit 99.11
|
Support
and Voting Agreement, dated as of October 19, 2007, by and among
Radiation Therapy Investments, LLC, Radiation Therapy Services Holdings, Inc.
and Michael J. Katin, including forms of Rollover Subscription Agreement,
Employment Agreement and Incentive Unit Subscription Agreement attached as
exhibits thereto.*
|
|
|
Exhibit 99.12
|
Form of
Management Agreement by and among Radiation Therapy Services, Inc.,
Radiation Therapy Services Holdings, Inc., Radiation Therapy
Investments, LLC and Vestar Capital Partners.
|
*
Incorporated by reference to the corresponding exhibits to the Schedule 13D
filed by the filing persons with the Securities and Exchange Commission on October 29,
2007.
12
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in this
statement is true, complete and correct.
December 21, 2007
|
RADIATION THERAPY INVESTMENTS, LLC
|
|
|
|
|
|
|
|
By:
|
/s/James L. Elrod, Jr.
|
|
Name:
James L. Elrod, Jr.
|
|
|
Title: President
|
|
|
|
|
|
|
|
|
VESTAR CAPITAL PARTNERS V, L.P.
|
|
|
|
|
By:
|
Vestar Associates V, L.P.,
|
|
|
its General Partner
|
|
|
|
|
By:
|
Vestar Managers V Ltd.,
|
|
|
its General Partner
|
|
|
|
|
|
|
|
By:
|
/s/James L. Elrod, Jr.
|
|
Name:
James L. Elrod, Jr.
|
|
|
Title: Managing Director
|
|
|
|
|
|
|
|
|
VESTAR ASSOCIATES V, L.P.
|
|
|
|
|
By:
|
Vestar Managers V Ltd.,
|
|
|
its General Partner
|
|
|
|
|
|
|
|
By:
|
/s/James L. Elrod, Jr.
|
|
Name:
James L. Elrod, Jr.
|
|
|
Title: Managing Director
|
|
|
|
|
|
|
|
|
VESTAR MANAGERS V LTD.
|
|
|
|
|
By:
|
/s/James L. Elrod, Jr.
|
|
Name:
James L. Elrod, Jr.
|
|
|
Title: Managing Director
|
|
|
|
|
|
13
|
/s/Daniel E. Dosoretz
|
|
Name: Daniel E. Dosoretz
|
|
|
|
|
|
|
|
|
|
|
|
/s/Howard M. Sheridan
|
|
Name: Howard M. Sheridan
|
|
|
|
|
|
|
|
|
|
|
|
/s/James H. Rubenstein
|
|
Name: James H. Rubenstein
|
|
|
|
|
|
|
|
|
|
|
|
/s/Michael J. Katin
|
|
Name: Michael J. Katin
|
|
|
|
|
14
Index of Exhibits
Exhibit 99.1
|
Amended
and Restated Joint Filing Agreement, dated December 26, 2007, by and
among the Reporting Persons.*
|
|
|
Exhibit 99.2
|
Agreement
and Plan of Merger, dated as of October 19, 2007, by and among Radiation
Therapy Services, Inc., Radiation Therapy Services Holdings, Inc.,
RTS MergerCo, Inc. and for purposes of Section 7.2 only, Radiation
Therapy Investments, LLC.*
|
|
|
Exhibit 99.3
|
Commitment
Letter, dated as of October 19, 2007, by and among Wachovia Bank,
National Association, Wachovia Investment Holdings, LLC, Wachovia Capital
Markets, LLC and Radiation Therapy Services Holdings, Inc.*
|
|
|
Exhibit 99.4
|
Equity
Commitment Letter, dated as of October 19, 2007, by and between Vestar
Capital Partners V, L.P. and Radiation Therapy Services Holdings, Inc.*
|
|
|
Exhibit 99.5
|
Form of
Amended and Restated Limited Liability Company Agreement of Radiation Therapy
Investments, LLC.*
|
|
|
Exhibit 99.6
|
Form of
Securityholders Agreement by and among Radiation Therapy Investments, LLC and
the securityholders party thereto.*
|
|
|
Exhibit 99.7
|
Form of
Radiation Therapy Investments, LLC 2008 Unit Award Plan.*
|
|
|
Exhibit 99.8
|
Support
and Voting Agreement, dated as of October 19, 2007, by and among
Radiation Therapy Investments, LLC, Radiation Therapy Services Holdings, Inc.
and Daniel E. Dosoretz, including forms of Rollover Subscription Agreement,
Employment Agreements and Incentive Unit Subscription Agreement attached as
exhibits thereto.*
|
|
|
Exhibit 99.9
|
Support
and Voting Agreement, dated as of October 19, 2007, by and among
Radiation Therapy Investments, LLC, Radiation Therapy Services Holdings, Inc.
and Howard M. Sheridan, including forms of Rollover Subscription Agreement,
Employment Agreement and Incentive Unit Subscription Agreement attached as
exhibits thereto.*
|
|
|
Exhibit 99.10
|
Support
and Voting Agreement, dated as of October 19, 2007, by and among
Radiation Therapy Investments, LLC, Radiation Therapy Services Holdings, Inc.
and James H. Rubenstein, including forms of Rollover Subscription Agreement,
Employment Agreements and Incentive Unit Subscription Agreement attached as
exhibits thereto.*
|
|
|
Exhibit 99.11
|
Support
and Voting Agreement, dated as of October 19, 2007, by and among
Radiation Therapy Investments, LLC, Radiation Therapy Services Holdings, Inc.
and Michael J. Katin, including forms of Rollover Subscription Agreement,
Employment Agreement and Incentive Unit Subscription Agreement attached as
exhibits thereto.*
|
|
|
Exhibit 99.12
|
Form of
Management Agreement by and among Radiation Therapy Services, Inc.,
Radiation Therapy Services Holdings, Inc., Radiation Therapy
Investments, LLC and Vestar Capital Partners.
|
*
Incorporated by reference to the corresponding exhibits to the Schedule 13D
filed by the filing persons with the Securities and Exchange Commission on October 29,
2007.
15